Physician profile
Carmen E Rosado
NPI 1154306926
$2,063.25
in general payments reported to CMS, 2019-2025
17 companies · $59.99 in 2025
The $59.99 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $398 · 2021: $492 · 2022: $238 · 2023: $380 · 2024: $131 · 2025: $59.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $404.50 | 2019-2024 | Pifeltro, Delstrigo, Dificid |
| Gilead Sciences, INC. | $363.41 | 2019-2024 | |
| Glaxosmithkline, LLC. | $360.95 | 2019-2024 | Shingrix, Bexsero, Arexvy |
| Vanda Pharmaceuticals INC. | $267.44 | 2020-2021 | |
| Abbvie INC. | $165.00 | 2019-2023 | Mavyret |
| Theratechnologies INC. | $139.74 | 2019-2024 | Trogarzo, Egrifta |
| Janssen Pharmaceuticals, INC | $55.87 | 2020 | |
| Amgen INC. | $54.91 | 2019-2023 | Repatha |
| Abbott Laboratories | $46.32 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.78 | 2022-2023 | |
| Alk-Abello, INC | $28.89 | 2023 | Grastek, Odactra, Ragwitek |
| Neurocrine Biosciences, INC. | $28.81 | 2019-2020 | |
| Cranial Technologies, INC | $28.80 | 2023-2025 | Doc Band |
| Therapeuticsmd, INC. | $27.85 | 2021-2022 | |
| Tris Pharma INC | $20.36 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.35 | 2023 | Thinprep 2000 Processor, Aptima |
| Janssen Biotech, INC. | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Rosado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.